{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:40:04Z","timestamp":1775853604079,"version":"3.50.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Giant cell arteritis (GCA) is an autoimmune vasculitis that affects large and medium-sized blood vessels. The mRNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has been associated with the development of immune-mediated diseases. In this article, we present a case of GCA that developed after vaccination against SARS-CoV2.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 77-year-old man developed fever, general fatigue, and headache 1 day after the third dose of vaccination against SARS-CoV2. Nodular swelling and tenderness of the bilateral temporal arteries were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Although right temporal artery biopsies were negative, the patient was diagnosed with GCA based on criteria established by the American College of Rheumatology for the classification of GCA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient received methylprednisolone 1000\u2009mg for 3 days. This was followed by prednisolone 1\u2009mg\/kg\/d, which was decreased by 10\u2009mg every week to 30\u2009mg. From day 16 of hospitalization, the patient received tocilizumab 162\u2009mg\/wk every other week.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>There was no occurrence of acute side effects. After 38 days of treatment, the condition improved and the patient was discharged from the hospital; as stated above, the dose of prednisolone was tapered to 30\u2009mg\/d.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We experienced a case of GCA that occurred immediately after vaccination against SARS-CoV2 with an mRNA vaccine. Early signs of GCA include fever, fatigue, and headache, and often resemble those noted after vaccination against SARS-CoV2. The potential presence of GCA should be determined in individuals with persistent fever and headache after vaccination against SARS-CoV2.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000033948","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:12:04Z","timestamp":1685718724000},"page":"e33948","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Development of giant cell arteritis after vaccination against SARS-CoV2: A case report and literature review"],"prefix":"10.1097","volume":"102","author":[{"given":"Hiroki","family":"Wakabayashi","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Iwayanagi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Sakai","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"},{"name":"Division of Rheumatology, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University Sakura Medical Center, Sakura, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Hiruta","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Toho University Sakura Medical Center, Sakura, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Matsuzawa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2647-9411","authenticated-orcid":false,"given":"Kaichi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American college of rheumatology 1990 criteria for the classification of giant cell arteritis.","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"102792102792","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity.","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"714170","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis.","volume":"12","author":"Sharif","year":"2021","journal-title":"Front Immunol"},{"key":"R4-20250504","first-page":"e21608","article-title":"A case of giant cell arteritis presenting after COVID-19 vaccination: is it just a coincidence?","volume":"14","author":"Greb","year":"2022","journal-title":"Cureus"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s10067-021-06041-7","article-title":"New-onset giant cell arteritis following COVID-19 mRNA (BioNTech\/Pfizer) vaccine: a double-edged sword?","volume":"41","author":"Anzola","year":"2022","journal-title":"Clin Rheumatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"105282105282","DOI":"10.1016\/j.jbspin.2021.105282","article-title":"SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? comment on: \u201ccan SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\u201d by Manzo et al. Joint Bone Spine 2021;88:105150.","volume":"89","author":"Cadiou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/qjmed\/hcac171","article-title":"Giant cell arteritis presenting with chronic cough and headache after BNT162b2 mRNA COVID-19 vaccination.","volume":"115","author":"Ishizuka","year":"2022","journal-title":"QJM"},{"key":"R8-20250504","first-page":"e25388","article-title":"A case of giant cell arteritis with a normal erythrocyte sedimentation rate (ESR) post ChAdOx1 nCoV-19 vaccination.","volume":"14","author":"Xia","year":"2022","journal-title":"Cureus"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases.","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:10:06Z","timestamp":1746324606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":9,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033948","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,2]]}}}